Literature DB >> 16342326

CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.

Christopher Alfonso1, Michael G McHeyzer-Williams, Hugh Rosen.   

Abstract

Thymic development requires proliferation, selection, maturation and release of mature single-positive CD4 and CD8 T cells into the periphery. In mice, non-selective sphingosine-1 phosphate (S1P) receptor agonists, active on four of the five known S1P receptors, alter thymocyte phenotype and egress. Here, we show that down-modulation of CD69 occurs acutely and transiently at a discrete and late stage of medullary development after a single-dose administration of S1P(1) receptor-selective agonist, which induces long-term tonic receptor activation in the absence of receptor degradation. In addition, agonist acutely inhibited egress of mature thymocytes into peripheral lymphoid organs, suggesting that both the phenotype and migration of medullary thymocytes are regulated simultaneously and coordinately by agonism of S1P(1) alone. Long-term dosing shifted the early/late medullary thymocyte ratio with an expansion of the late medullary compartment, as mature CD69(-) thymocytes were retained within the thymus. Therefore, chemical agonism of S1P(1) accelerates medullary phenotypic maturation and inhibits egress, leading to the expansion and accumulation of the recent thymocyte emigrant population in the medulla. However, chemical agonism fails to replicate the S1P(1)-null CD69(hi) late medullary phenotype, suggesting that agonism and gene deletion operate by distinct mechanisms, and that functional receptor antagonism may not be required for lymphocyte sequestration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16342326     DOI: 10.1002/eji.200535127

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  Dynamic regulation of miRNA expression in ordered stages of cellular development.

Authors:  Joel R Neilson; Grace X Y Zheng; Christopher B Burge; Phillip A Sharp
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

Review 2.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

3.  Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.

Authors:  Stephan C Schürer; Steven J Brown; Pedro J Gonzalez-Cabrera; Marie-Therese Schaeffer; Jacqueline Chapman; Euijung Jo; Peter Chase; Tim Spicer; Peter Hodder; Hugh Rosen
Journal:  ACS Chem Biol       Date:  2008-07-01       Impact factor: 5.100

4.  Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype.

Authors:  Mariangela Urbano; Miguel Guerrero; Subash Velaparthi; Melissa Crisp; Peter Chase; Peter Hodder; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2011-09-20       Impact factor: 2.823

5.  Discovery, design and synthesis of the first reported potent and selective sphingosine-1-phosphate 4 (S1P4) receptor antagonists.

Authors:  Miguel Guerrero; Mariangela Urbano; Subash Velaparthi; Jian Zhao; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2011-04-28       Impact factor: 2.823

6.  B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis.

Authors:  Rajesh K Sinha; Chung Park; Il-Young Hwang; Michael D Davis; John H Kehrl
Journal:  Immunity       Date:  2009-02-19       Impact factor: 31.745

Review 7.  The vascular S1P gradient-cellular sources and biological significance.

Authors:  Timothy Hla; Krishnan Venkataraman; Jason Michaud
Journal:  Biochim Biophys Acta       Date:  2008-07-28

Review 8.  The alliance of sphingosine-1-phosphate and its receptors in immunity.

Authors:  Juan Rivera; Richard L Proia; Ana Olivera
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

9.  Sphingosine 1-phosphate receptor 1 (S1P(1)) upregulation and amelioration of experimental autoimmune encephalomyelitis by an S1P(1) antagonist.

Authors:  Stuart M Cahalan; Pedro J Gonzalez-Cabrera; Nhan Nguyen; Miguel Guerrero; Elizabeth A George Cisar; Nora B Leaf; Steven J Brown; Edward Roberts; Hugh Rosen
Journal:  Mol Pharmacol       Date:  2012-11-30       Impact factor: 4.436

10.  Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.

Authors:  Pedro J Gonzalez-Cabrera; Euijung Jo; M Germana Sanna; Steven Brown; Nora Leaf; David Marsolais; Marie-Therese Schaeffer; Jacqueline Chapman; Michael Cameron; Miguel Guerrero; Edward Roberts; Hugh Rosen
Journal:  Mol Pharmacol       Date:  2008-08-15       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.